Abstract
Antimalarial Drug Prescription: Evaluation of the Healthcare Professionals based on the Malian National Malaria Control Program (NMCP) Guidelines
Highlights
The World Health Organization (WHO) estimates worldwide were 228 million cases of malaria and 405,000 deaths in 2018 as compared to 219 million cases including 435,000 deaths in 2017
A large proportion of antimalarial prescriptions were not conform to the National Malaria Control Program (NMCP) guidelines at our study sites in Mali
Prescriptions were made when the diagnostic of malaria was confirmed by the rapid diagnostic test (RDT) and thick blood smear in Kangaba (83.3%) and in Bougouni (87.8%) (Table 3)
Summary
The World Health Organization (WHO) estimates worldwide were 228 million cases of malaria and 405,000 deaths in 2018 as compared to 219 million cases including 435,000 deaths in 2017. Most malaria cases occur in sub-Saharan Africa in children under fiveyears-old and pregnant women [1]. In Mali, malaria remains a major endemic and leading cause of morbidity and mortality in health centers [2]. Despite the decreasing burden of malaria in our country through extensive success of the National Malaria Eradication Program (NMEP), the national health statistics show that malaria is still rang first among all diseases; It represents 39% of all outpatient visits in the health center and affects 19% of children under five-years-old [2]. It was used to treat uncomplicated malaria or in the chemoprophylaxis.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
